---
title: "Zhongxing BioTech: Recently, there have been no significant changes in the company's operating conditions or the internal and external operating environment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257226898.md"
description: "Zhongxing BioTech announced on September 14th that there have been no significant changes in the company's operating conditions and internal and external business environment recently. The cumulative price deviation of the company's stock closing price has exceeded 20% over three consecutive trading days, which constitutes an abnormal fluctuation in stock trading. After verification, it was confirmed that there is no need to correct or supplement the previously disclosed information, and no undisclosed significant information that could affect the stock trading price has been found. Internal production and business activities are normal, and the controlling shareholder and actual controller did not buy or sell the company's stock during the period of abnormal fluctuation"
datetime: "2025-09-14T07:48:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257226898.md)
  - [en](https://longbridge.com/en/news/257226898.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257226898.md)
---

# Zhongxing BioTech: Recently, there have been no significant changes in the company's operating conditions or the internal and external operating environment

Zhongxing BioTech announced on September 14th that the cumulative price deviation of its stock closing price has exceeded 20% over three consecutive trading days. According to the relevant regulations of the Shenzhen Stock Exchange, this constitutes an abnormal fluctuation in stock trading. After verification, the company confirmed that there are no corrections or supplements needed for the information previously disclosed. The company has not found any recent public media reports that may have significantly impacted the trading price of its stock due to undisclosed material information. Recently, the company's operating conditions and internal and external business environment have not undergone significant changes, and internal production and operational activities are proceeding normally. The company, its controlling shareholders, and actual controllers do not have any significant matters that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage. During the period of abnormal fluctuations in stock trading, the controlling shareholders and actual controllers did not engage in buying or selling the company's stock

### Related Stocks

- [002772.CN](https://longbridge.com/en/quote/002772.CN.md)

## Related News & Research

- [LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study](https://longbridge.com/en/news/296106866.md)
- [REG - Origin Enterprises - Holding(s) in Company](https://longbridge.com/en/news/296240027.md)
- [TGN: Net profit fell 51% year-over-year, but market cap reached a record high amid major investments](https://longbridge.com/en/news/296490198.md)
- [Fleury launches BRL 1.83 billion two-tranche unsecured debenture offering](https://longbridge.com/en/news/296407363.md)
- [Masoval to present Q2 2026 results in investor briefing](https://longbridge.com/en/news/296509895.md)